ST
ELV icon

Spot Trading’s Elevance Health ELV Stock Holding History

Spot Trading’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-634
Closed -$114K – 3229
2017
Q1 		$105K Buy
+634
New +$101K ﹤0.01% 2236
2016
Q3 		– Sell
-111
Closed -$14.3K – 3171
2016
Q2 		$15K Hold
111
– – ﹤0.01% 3023
2016
Q1 		$15K Sell
111
-3,857
-97% -$515K ﹤0.01% 3075
2015
Q4 		$553K Sell
3,968
-7,670
-66% -$1.06M 0.01% 1855
2015
Q3 		$1.63M Buy
11,638
+6,009
+107% +$903K 0.02% 1226
2015
Q2 		$924K Sell
5,629
-10,099
-64% -$1.61M 0.01% 1691
2015
Q1 		$2.43M Buy
+15,728
New +$2.24M 0.02% 981
2014
Q4 		– Sell
-50,481
Closed -$6.04M – 4114
2014
Q3 		$6.04M Buy
+50,481
New +$5.79M 0.03% 822
2014
Q1 		– Sell
-1,520
Closed -$137K – 4276
2013
Q4 		$140K Buy
+1,520
New +$135K ﹤0.01% 3178
2013
Q3 		– Sell
-91
Closed -$7.8K – 4173
2013
Q2 		$7K Buy
+91
New +$6.81K ﹤0.01% 4013

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Spot Trading's ELV Position: Q2 2017 in Review

Spot Trading sold out of Elevance Health (ELV) in Q2 2017, closing a stake of 634 shares — an estimated $114K sold.

Spot Trading first reported a position in ELV in Q2 2013 and held it in 10 quarters. The position peaked at $6.04M in Q3 2014. 852 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

  • Spot Trading reported no remaining Elevance Health position as of Q2 2017 after selling out during the quarter.
  • Spot Trading sold 634 Elevance Health shares in Q2 2017, an estimated $114K.
  • Spot Trading first reported a position in Elevance Health in Q2 2013 and held it in 10 quarters.
  • Spot Trading's Elevance Health position peaked at $6.04M in Q3 2014.
  • 852 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on Spot Trading's 13F filing for Q2 2017, filed 27 Jul 2017.